Heart rate variability in childhood obesity
Received: 10 September 2000 Accepted: 26 April 2001 DOI:
Cite this article as: Martini, G., Riva, P., Rabbia, F. et al. Clinical Autonomic Research (2001) 11: 87. doi:10.1007/BF02322051 Abstract
Obesity is characterized by hemodynamic and metabolic alterations. Autonomic control on cardiac function involvement is controversial. The aim of the study was to assess early sign of cardiac autonomic dysfunction in obesity, using time- and frequency-domain heart rate variability (HRV) analysis in a pediatric population. Methods: 32 obese children (OB) (17 M, 15 F; 13.9±1.7 y) were compared with 13 healthy lean subjects (7M, 6F; 12.9±1.6y). For each participant, the authors performed a clinical examination, laboratory testing, blood pressure (BP) measurements, and 24-hour electrocardiograph/ambulatory BP monitoring. The spectral power was quantified in total power, low-frequency (HF) power, index of sympathetic tone, high-frequency (HF) power, index of vagal tone, and LF/HF ratio. Low frequency and HF were averaged to obtain 3 measures: 24-hour, daytime, and nighttime levels. Total, long-term, and short-term time-domain HRV values were calculated. Results: The obese children had higher casual and ambulatory BP, and higher fasting glucose, insulin, and triglyceride levels. Overall HRV values were not significantly lower in OB. The obese children had significantly lower 24-hour and nighttime high-frequency normalized units, and time-domain measures of vagal activity. Low-frequency power showed an inverse but not significant pattern. The OB group had significantly greater 24-hour and nighttime LF/HF ratios. Conclusions: The authors found an increase in heart rate and in BP associated with parasympathetic heart rate control decrease in stabilized obese normotensive children.
Key words obesity heart rate variability autonomic cardiac control pediatric hypertension References
Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension.
Arch Intern Med
Kannel WB, Dawber TR. Atherosclerosis as a pediatric problem.
Johnson BC, Epstein FH, Kjelsberg MO. Distributions and familial studies of blood pressure and serum cholesterol in a total community-Tecumseh, Michigan.
J Chron Dis
Folsom AR, Jacobs DR Jr, Wagenknecht LE, et al. Increase in fasting insulin and glucose over seven years with increasing weight and inactivity of young adults: the CARDIA Study.
Am J Epidemiol
Liu K, Ruth KJ, Flack JM, et al. Blood pressure in young blacks and white: relevance of obesity and lifestyle factors in determining differences: the CARDIA Study.
Manson JE, Willet WC, Stampfer MJ, et al. Body weight and mortality among women.
N Engl J Med
Hoffmans M, Kromhout D, de Lezenne Coulander C. The impact of body mass index of 78.312 18-year-old Dutch men on 32-year mortality from all causes.
J Clin Epidemiol
Sowers JR, Whitfield LA, Catania RA, et al. Role of the sympathetic nervous system in blood pressure maintenance in obesity.
J Clin Endocrinol Metab
Tuck ML, Sowers JR, Dornfeld L, et al. Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects.
Troisi RJ, Weiss ST, Parker DR, et al. Relation of obesity and diet to sympathetic nervous system activity.
Young JB, McDonald IA. Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980.
Int J Obes Relat Metab Disord
Adehlman ET, Gardner AW, Goran MI, et al. Sympathetic nervous system activity, body fatness and body fat distribution in young and older males.
J Appl Physiol 1995; 78:802–806.
Vaz M, Jennings G, Turner A, et al. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation in obese normotensive subjects,
Scherrer U, Randin D, Tappy L, et al. Body fat and sympathetic nerve activity in healthy subjects.
Rumantir MS, Vaz M, Jennings GL, et al. Neural mechanisms in human obesity-related hypertension.
Young J, Ladsberg L. Dimishished sympathetic nervous system activity in genetically obese (ob/ob) mouse.
Am J Physiol
Narkiewicz K, Van de Borne PJH, Cooley RL, et al. Sympathetic activity in obese subjects with and without obstructive sleep apnoea.
Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions.
Rolland-Cacherà MF, Deheeger M, Bellisle F, et al. Adiposity rebound in children: a simple indicator for predicting obesity.
Am J Clin Nutr 1994; 39(1):129–135.
Berntson GG, Quigley KS, Jang JF, et al. An approach to artifact identification: application to heart period data.
Kamath ML, Fallen EL. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function.
Crit Rev Biomed Eng
Berntson GG, Bigger JT, Eckberg DL, et al. Heart rate variability: origins, methods, and interpretative caveats.
Ewing DJ, Neilson JMM, Travis P. New method for assessing cardiac parasympathetic activity using 24-hour electrocardiograms.
Br Heart J 1984; 52:17–28.
Von Neumann J, Kent RH, Bellinson HR. The mean square successive difference.
Ann Math Stat 1941; 12:153–162.
Peterson HR, Rothschild M, Wienberg CR, et al. Body fat and the activity of the autonomic nervous system.
N Engl J Med
Rossi M, Marti G, Ricordi L, et al. Cardiac autonomic disfunction in obese subjects.
Grassi G, Seravalle G, Cattaneo BM, et al. Sympathetic activation obese normotensive subjects.
Arone LJ, Mackintosh R, Rosembaum M, et al. Autonomic nervous system activity in weight gain and weight loss.
Am J Physiol 1995; 169(pt 1):R222-R225.
Peterson H, Rothschild M, Weinberg C, et al. Body fat and the activity of the autonomic nervous system.
N Engl J Med
Piccirillo G, Vetta F, Fimognari F, et al. Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness.
Int J Obesity 1996; 20:825–829.
Hirsch J, Leibel R, Mackintosh R, et al. Heart rate variability as a measure of autonomic function during weight change in human.
Am J Physiol
Landsberg L. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous, and adaptative thermogenesis.
Sowers JR, Nyby M, Stern N, et al. Blood pressure and hormonal changes associated with weight reduction in the obese.
Landsberg L, Young JB. Fasting, feeding and regulation of the sympathetic nervous system activity.
N Engl J Med
Grassi G, Seravalle G, Colombo M, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.
Spraul M, Ravussin E, Fontvieille AM, et al. Reduced Sympathetic nervous activity. A potential mechanism predisposing to body weight gain.
J Clin Invest
Christin L, O'Connell M, Bogardus E, et al. Norepinephrine turnover and energy expenditure in Pima Indian and white men.
Gao Y, Lovejoy J, Sparti A, et al. Autonomic activity assessed by heart rate spectral analysis varies with fat distribution in obese women.
Bunag RD, Barringer DL. Obese Zucker rats, thought still normotensive, already have impaired chronotropic baroreflexes.
Clin Exp Hypertens 1988; 10(suppl 1, pt A):257–262.
Bunag RD, Eriksson L, Krizsan D. Baroreceptor reflex impairment and mild hypertension in rats with diet induced obesity.
Van Vliet BN, Hall JE, Mizelle HL, et al. Reduced parasympathetic control of heart rate in obese dogs.
Am J Physiol
1995; 269(pt 2):H629-H637.
Hedman AE, Tahvanainen KUO, Hartikainen JEK, et al. Effect of sympathetic modulation and sympatho-vagal interaction on heart rate variability in anaesthetized dogs.
Acta Physiol Scand
Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use.
Circulation 1996; 93:1043–1065.
Verwaerde P, Sénard JM, Galinier M, et al. Changes in short-term variability of blood pressure and heart rate during the development of obesity-associated hypertension in high-fat fed dogs.
CrossRef PubMed Copyright information
© Lippincott Williams & Wilkins 2001